The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

Immuno Cure BioTech and PharmaJet are working together on a clinical study to test the effectiveness of PharmaJet’s ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

For nearly 15 years, Dennis Burton worked on a project aimed at solving what he calls "one of the most difficult problems in ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...

Groundbreaking single-dose vaccine found effective in preventing HIV - Strategy may lead to new vaccines that only need to be ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

The University City organization debuted its new facility days after the Trump administration cut funding for promising ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...